3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
13
OTHER
8
FED
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Classical hematology
1
Conditions
Prostatic Neoplasms
17
Rare Diseases
3
Neoplasms
3
Neoplasm Metastasis
3
Leukemia
3
Recurrence
2
Lymphoma
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Genetic Diseases, Inborn
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Squamous Cell
2
Adenocarcinoma Of Esophagus
2
Turcot syndrome
1
Small Cell Lung Carcinoma
1
Sezary Syndrome
1
Respiratory Aspiration
1
Radiation Pneumonitis
1
Prostate Cancer Diagnosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Oropharyngeal Neoplasms
1
Oligodendroglioma
1
Non-Muscle Invasive Bladder Neoplasms
1
Newly Diagnosed Oligometastatic Prostate Cancer
1
Neuroma, Acoustic
1
Neurologic Manifestations
1
Neurofibromatosis 2
1
Neurofibromatoses
1
Interventions
olaparib
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
FED
×
Hereditary Sensory and Autonomic Neuropathies
×
Clear all
NCT04038502
2025-08-20
COBRA
VA Office of Research and Development
Phase 2
Recruiting
100 enrolled